Stay updated on Durvalumab Combo in Resectable NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab Combo in Resectable NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab Combo in Resectable NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-01T13:58:02.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A notice about NIH’s transition from the term “artificial intelligence” to “super intelligence” appears above the clinical trial record.
    Difference
    0.5%
    Check dated 2026-10-25T13:27:28.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-18T13:50:58.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer site revision changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T15:19:08.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    - The record history now includes a new revision entry (v3.7.0) and removes the previous revision (v3.6.6), reflecting an update to the page's version history. This indicates an administrative update to the page rather than substantive study data.
    Difference
    0.1%
    Check dated 2026-09-20T20:29:04.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    The record history now shows a new revision label, v3.6.6, as the current version, replacing the previous v3.6.5. This reflects an updated version of the study record rather than a change to the study data itself.
    Difference
    0.1%
    Check dated 2026-08-30T06:44:30.000Z thumbnail image

Stay in the know with updates to Durvalumab Combo in Resectable NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Resectable NSCLC Clinical Trial page.